Jared Gollob, Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR), sold 5,366 shares at $41.41 ($224K) on 2024-03-04, disclosed to the SEC on 2024-03-04.
Seasonal sale ($224k) by Chief Medical Officer — this insider has traded KYMR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.41 | 2,022 | $84K | 37.4% |
| 2 | $41.41 | 2,022 | $84K | 37.4% |
| 3 | $42.39 | 1,106 | $47K | 21.0% |
| 4 | $43.26 | 216 | $9K | 4.2% |
| Total | $41.69 avg | 5,366 | $224K | 100% |
| Filing → |
| KYMR | SELL | 2025-10-15 | $7.3M | — | Filing → |
| KYMR | SELL | 2025-10-14 | $187K | — | Filing → |
| KYMR | SELL | 2025-03-03 | $317K | — | Filing → |